Made possible with a $4 million grant from the Brazilian Ministry of Health, CHOP cell therapy specialists will offer their expertise and resources to oversee this initiative.

Dr. Lori Handy recommends that you speak with your healthcare provider or travel clinic regarding vaccines or medications important for your international travel destination.

Download a copy of our updated vaccine safety booklet. Check out recent data about vaccine rates among kindergartens and what it means.

Find info about primary vs. secondary sources when evaluating information about a scientific study.

CHOP’s Center for Fetal Diagnosis and Treatment and Fetal Heart Program, performs fourth successful fetal heart surgery to remove life-threatening tumor.

Three questions on modified health questionnaire were more likely to predict suicidal behavior within one year of screening

Making kidney-friendly foods at home can be hard when a family has food insecurity. Our Food Opportunities to Improve Outcomes in Dialysis (FOOD) program is here to help.

At CHOP's Helping Hands event, volunteers engaged in a day of service to fundraise and make kits for patients.

Patients who are non-Hispanic Black, possess public insurance, and have lower markers of childhood opportunity were more likely to be seen first for a concussion in the emergency department, potentially impacting follow-up care

Researchers at Children’s Hospital of Philadelphia (CHOP) found that emicizumab, a widely used drug for hemophilia A, could also improve blood clotting for select people with hemophilia B depending on their genes. The preclinical study, recently published in Blood, offers proof that this class of hemophilia A drug could potentially be used to treat hemophilia B.